Vanguard Group Inc Increases Stake in TuHURA Biosciences Inc

The Vanguard Group Inc has filed an amendment to its Schedule 13G, reporting an increased stake in TuHURA Biosciences Inc. As of September 30, 2025, Vanguard holds 2,269,666 shares, representing a 4.44% ownership in the company. This marks an increase of 35,426 shares from the previous filing, with the value of the holdings rising by approximately $805,293 to $5,787,648. The filing indicates that Vanguard's clients, including investment companies and managed accounts, have the right to receive dividends or proceeds from the sale of these securities. The amendment was signed by Ashley Grim, Head of Global Fund Administration, on October 31, 2025.